TMDX
TransMedics Group Inc
79.80$
+1.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 77.9% | 72.3% | 67.5% | 67.1% | 62.7% | 61.8% | 60.4% | 62.7% | 64.8% | 59.7% | 43.2% | 44.5% | |
| 62.0% | 55.9% | 48.4% | 47.8% | 42.0% | 41.9% | 37.0% | 45.0% | 49.3% | 45.7% | 32.2% | 32.3% | |
| 62.0% | 55.9% | 48.4% | 47.8% | 42.0% | 41.9% | 37.0% | 45.0% | 49.3% | 45.7% | 32.2% | 32.3% | |
| 8.8% | 9.0% | 11.3% | 10.7% | 11.5% | 12.2% | 17.0% | 11.8% | 8.5% | 7.9% | 6.3% | 7.1% | |
| 5.7% | 6.3% | 6.7% | 6.4% | 6.6% | 5.8% | 5.2% | 4.4% | 4.7% | 4.6% | 3.5% | 3.7% | |
| 1.7% | 1.7% | 1.7% | 1.5% | 1.5% | 1.4% | 1.4% | 1.3% | 1.2% | 1.1% | 0.8% | 0.8% | |
| 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.2% | 0.2% | 0.2% | – | – | |
| 81.7% | 80.6% | 78.0% | 75.0% | 73.3% | 71.6% | 68.2% | 64.3% | 62.5% | 55.7% | 65.6% | 64.6% | |
| 7.1% | 7.8% | 6.9% | 7.2% | 7.6% | 7.5% | 6.6% | 6.4% | 8.4% | 8.4% | 6.4% | 6.7% | |
| 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.9% | 1.2% | 1.3% | 1.6% | |
| 1.9% | 1.8% | 1.3% | 1.7% | 1.7% | 1.3% | 1.3% | 1.1% | 1.3% | 1.0% | 0.8% | 4.9% | |
| 73.3% | 71.7% | 70.0% | 66.9% | 64.7% | 63.3% | 60.9% | 57.4% | 53.6% | 47.0% | 34.7% | 33.7% | |
| 18.3% | 19.4% | 22.0% | 25.0% | 26.7% | 28.4% | 31.8% | 35.7% | 37.5% | 44.3% | 34.4% | 35.4% | |
| -73.7% | -71.3% | -67.9% | -63.2% | -60.5% | -58.2% | -52.8% | -45.8% | -40.5% | -26.0% | -18.9% | -17.5% | |
| 4.7% | 4.8% | 4.8% | 4.7% | 4.5% | 4.4% | 4.8% | 4.6% | 4.3% | 3.8% | 2.5% | 2.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.